Picton Mahoney Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-650
Closed -$82K 940
2024
Q2
$82K Buy
650
+160
+33% +$25.1K ﹤0.01% 358
2024
Q1
$90K Sell
490
-10
-2% -$1.9K ﹤0.01% 292
2023
Q4
$90K Buy
+500
New +$77.8K ﹤0.01% 349
2023
Q2
Sell
-965
Closed -$163K 476
2023
Q1
$163K Buy
965
+245
+34% +$43.7K 0.01% 350
2022
Q4
$122K Sell
720
-30
-4% -$5.44K 0.01% 521
2022
Q3
$141K Sell
750
-75
-9% -$15.8K 0.01% 534
2022
Q2
$134K Sell
825
-830
-50% -$131K 0.01% 637
2022
Q1
$311K Sell
1,655
-3,840
-70% -$729K 0.01% 637
2021
Q4
$1.46M Sell
5,495
-1,660
-23% -$447K 0.04% 512
2021
Q3
$2.07M Sell
7,155
-280
-4% -$71.8K 0.08% 307
2021
Q2
$1.49M Buy
+7,435
New +$1.44M 0.04% 446
2020
Q4
Sell
-7,215
Closed -$1.06M 395
2020
Q3
$1.06M Buy
7,215
+735
+11% +$105K 0.06% 256
2020
Q2
$802K Buy
+6,480
New +$762K 0.05% 230

Other funds holding RGEN

Picton Mahoney Asset Management's RGEN Position: Q3 2024 in Review

Picton Mahoney Asset Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 650 shares — an estimated $82K sold.

Picton Mahoney Asset Management first reported a position in RGEN in Q2 2020 and held it in 13 quarters. The position peaked at $2.07M in Q3 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Picton Mahoney Asset Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 650 Repligen shares in Q3 2024, an estimated $82K.
  • Picton Mahoney Asset Management first reported a position in Repligen in Q2 2020 and held it in 13 quarters.
  • Picton Mahoney Asset Management's Repligen position peaked at $2.07M in Q3 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2024, filed 4 Nov 2024.